Projects per year
Personal profile
Education
- 1981 Ph.D., Biochemistry, Lille Science and Technology University, France
- 1977 Master of Science, Biochemistry, Lille Science and Technology University, France
- 1976 Bachelor of Science, Lille Science and Technology University, France
Experience
- Distinguished Professor, College of Biomedical Engineering, Taipei Medical University
- 2020.01- Professor, Ph.D. Program in Neuroscience of Cognition and Consciousness, Taipei Medical University
- 2018.02- Professor, International Ph.D Program for Cell Therapy and Regeneration Medicine, Taipei Medical University
- 2017.10- Vice Dean, College of Biomedical Engineering, Taipei Medical University
- 2016.08- Director International PhD Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University
- 2015.08- Professor, Graduate Institute of Biomaterials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University
- 2014- Treasurer, Working Party on Cellular Therapies, International Society of Blood Transfusion
- 2012- Organising Committee member of the Working Party of Global Blood Safety, International Society of Transfusion Medicine
- 2013.08-2015 Director, Graduate Institute of Biomaterials and Tissue Engineering, College of Oral Medicine, Taipei Medical University
- 2012.08-2015 Professor, Graduate Institute of Biomaterials and Tissue Engineering, College of Oral Medicine, Taipei Medical University
- 2008.08- Taipei Medical University, Taipei, Taiwan
- 2008.08-2012.08 Visiting Professor, Graduate Institute of Medical Sciences, College of Oral Medicine ; “Foreign Expert” laureate from the National Science Council (NSC) of Taiwan
- 1998.01-2012 Human Protein Process Sciences, Lille, France
- Director
- Expert and International Consultant for Process and Biological product development (human blood & plasma products, recombinant products, animal-derived antisera); supervises research and development work on biological products
- World Health Organization Expert
- 1995.09-1997.12 Haemonetics Corporation, Boston, Ma., USA
- Vice President, Haemonetics Corporation, Boston, USA
- Director, Haemonetics Plasma product Services (HPPS), Nyon, Switzerland
- Member of the International Management Committee
- 1994.06-1995.09 Laboratoire Français du Fractionnement et des Biotechnologies (French National Plasma Fractionation and Biotechnology Laboratory), Paris, France
- 1995.01-1995.09 National Scientific Director (120 researchers and assistants)
- 1995.01 General Manager, Lille plasma fractionation plant (280 employees)
- Member of the Executive Committee, International Committee, and Scientific Committee
- 1986.09-1994.06 Regional Blood Transfusion Center - Lille - CRTS-Lille, France
- 1990 Director, plasma fractionation centre (150 employees)
- 1986 Chief of Department, plasma fractionation service (350 employees)
- Member of the Executive Committee
- 1984.10-1986.09 Regional Blood Transfusion Center - Lille - CRTS-Lille, France
- Chief of Research and Development laboratory
- 1982.05-1984.10 Northern Regional Research Center, USDA, Peoria, Illinois, USA
- Post-doctoral Research Assistant (University of Nebraska, Lincoln, USA), based at the Northern Regional Research Centre, IL., USA
Awards
- MOST Outstanding Research Award in 2021
- TMU excellent research award in 109 academic year
- 2019 Award from the International Plasma Fractionation Association
-
Outstanding research papers award in 106 academic year
- Award for Recruitment and Retention of Special and Outstanding Talents by MOST in 106 academic year
- Outstanding research papers award in 105 academic year
- Excellent Teacher Award in 105 academic year
Research Interests
- Platelet growth factors for regenerative medicine and cell therapy
- Plasma fractionation
- Viral inactivation technologies
- Blood biotechnology
Related Link
Fingerprint
Dive into the research topics where Thierry Pierre Robert Burnouf is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
研究凝血酶/近紅外光應答結合抗凝血磺酸化胜肽載體於模擬血栓晶片的循環流場中之作用效益
1/1/22 → 12/31/22
Project: B - Project of TMU › h - Higher Education Sprout Project
-
Growth Factors-Rich Evs-Functionalized Graphene-On-Hydrogel Based Skin Bioactive Regeneration Scaffolds( I )
1/1/22 → 12/31/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
Platelet Microvesicles as Targeted Anti-cancer Drug Delivery Tools
1/1/22 → 12/31/22
Project: A - Government Institution › a - National Health Research Institutes
-
Bio-Engineered Platelet Secretome Biomaterials for Brain Rejuvenation( I )
8/1/21 → 7/31/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
研究凝血酶/近紅外光應答結合抗凝血磺酸化胜肽載體於模擬血栓晶片的循環流場中之作用效益
1/1/21 → 12/31/21
Project: B - Project of TMU › h - Higher Education Sprout Project
Research output
-
Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment response in patients with pancreatic ductal adenocarcinoma
Wu, Y. H., Hung, Y. P., Chiu, N. C., Lee, R. C., Li, C. P., Chao, Y., Shyr, Y. M., Wang, S. E., Chen, S. C., Lin, S. H., Chen, Y. H., Kang, Y. M., Hsu, S. M., Yen, S. H., Wu, J. Y., Lee, K. D., Tseng, H. E., Tsai, J. R., Tang, J. H., Chiou, J. F. & 4 others, , May 2022, In: European Journal of Cancer. 166, p. 208-218 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Experience with COVID-19 convalescent plasma provides vital guidance to future pandemics
Hartmann, J., Bloch, E. M. & Burnouf, T., 2022, (Accepted/In press) In: Transfusion. 62, 3, p. 681-684 4 p.Research output: Contribution to journal › Comment/debate › peer-review
1 Citation (Scopus) -
International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID-19 pandemic
the ISBT COVID-19 Convalescent Plasma Working Group, 2022, (Accepted/In press) In: Vox Sanguinis.Research output: Contribution to journal › Article › peer-review
-
Near-infrared-driven photoablation of lung cancer tumors utilizing biomimetic platelet-polyethyleneimine-polypyrrole drug-free nanoparticles
Burnouf, T., Jheng, P. R., Chen, Y. H., Rethi, L., Rethi, L., Lu, L. S., Ho, Y. C. & Chuang, E. Y., Mar 2022, In: Materials and Design. 215, 110481.Research output: Contribution to journal › Article › peer-review
Open Access -
Regenerative effect of expired platelet concentrates in human therapy: An update
Burnouf, T. & Goubran, H. A., 2022, (Accepted/In press) In: Transfusion and Apheresis Science. 61, 1, 103363.Research output: Contribution to journal › Review article › peer-review
1 Citation (Scopus)
Datasets
-
Additional file 7 of Clinical-grade cryopreserved doxorubicin-loaded platelets: role of cancer cells and platelet extracellular vesicles activation loop
Wu, Y. (Contributor), Huang, C. (Contributor), Changou, C. A. (Contributor), Lu, L. (Contributor), Goubran, H. (Contributor) & Burnouf, T. P. R. (Contributor), Unknown Publisher, Mar 23 2020
DOI: 10.6084/m9.figshare.12017397.v1, https://springernature.figshare.com/articles/Additional_file_7_of_Clinical-grade_cryopreserved_doxorubicin-loaded_platelets_role_of_cancer_cells_and_platelet_extracellular_vesicles_activation_loop/12017397/1
Dataset
-
Additional file 8 of Clinical-grade cryopreserved doxorubicin-loaded platelets: role of cancer cells and platelet extracellular vesicles activation loop
Wu, Y. (Contributor), Huang, C. (Contributor), Changou, C. A. (Contributor), Lu, L. (Contributor), Goubran, H. (Contributor) & Burnouf, T. P. R. (Contributor), Unknown Publisher, Mar 23 2020
DOI: 10.6084/m9.figshare.12017403.v1, https://springernature.figshare.com/articles/Additional_file_8_of_Clinical-grade_cryopreserved_doxorubicin-loaded_platelets_role_of_cancer_cells_and_platelet_extracellular_vesicles_activation_loop/12017403/1
Dataset
-
Additional file 2 of Clinical-grade cryopreserved doxorubicin-loaded platelets: role of cancer cells and platelet extracellular vesicles activation loop
Wu, Y. (Contributor), Huang, C. (Contributor), Changou, C. A. (Contributor), Lu, L. (Contributor), Goubran, H. (Contributor) & Burnouf, T. P. R. (Contributor), Unknown Publisher, Mar 23 2020
DOI: 10.6084/m9.figshare.12017382.v1, https://springernature.figshare.com/articles/Additional_file_2_of_Clinical-grade_cryopreserved_doxorubicin-loaded_platelets_role_of_cancer_cells_and_platelet_extracellular_vesicles_activation_loop/12017382/1
Dataset
-
Additional file 4 of Clinical-grade cryopreserved doxorubicin-loaded platelets: role of cancer cells and platelet extracellular vesicles activation loop
Wu, Y. (Contributor), Huang, C. (Contributor), Changou, C. A. (Contributor), Lu, L. (Contributor), Goubran, H. (Contributor) & Burnouf, T. P. R. (Contributor), Unknown Publisher, Mar 23 2020
DOI: 10.6084/m9.figshare.12017388.v1, https://springernature.figshare.com/articles/Additional_file_4_of_Clinical-grade_cryopreserved_doxorubicin-loaded_platelets_role_of_cancer_cells_and_platelet_extracellular_vesicles_activation_loop/12017388/1
Dataset
-
Additional file 3 of Clinical-grade cryopreserved doxorubicin-loaded platelets: role of cancer cells and platelet extracellular vesicles activation loop
Wu, Y. (Contributor), Huang, C. (Contributor), Changou, C. A. (Contributor), Lu, L. (Contributor), Goubran, H. (Contributor) & Burnouf, T. P. R. (Contributor), Unknown Publisher, Mar 23 2020
DOI: 10.6084/m9.figshare.12017385.v1, https://springernature.figshare.com/articles/Additional_file_3_of_Clinical-grade_cryopreserved_doxorubicin-loaded_platelets_role_of_cancer_cells_and_platelet_extracellular_vesicles_activation_loop/12017385/1
Dataset